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Abstract
Aim: To evaluate fundamental cell functions, such as adhesion, IL-6 production and proliferation
of human gingival keratinocytes cultured on a newly engineered collagen matrix (CM-10826) and
to assess the degree of specific biocompatibility of this new device.
Materials and methods: Primary cultures of human keratinocytes were derived “in vitro” from
biopsies of independent donors. Their true epithelial origin was ensured by the expression of
cytokeratin 14. Adhesion, proliferation and production of IL-6 cytokine was then measured in the
presence or absence of CM-10826 activity or of its relevant components.
Results: Functional tests revealed that keratinocytes adhered to CM-10826 and up-regulated their
basal IL-6 production. The type of keratinocytes used expressed cytokeratin 14. Proliferation
experiments demonstrated that the best cellular response was observed in the presence of
Collagen I, the main component of CM-10826. No undesired effects were observed as for
keratinocyte viability, morphology or differentiation.
Conclusions: Our results demonstrate that CM-10826 has a favourable biological effect on the “in
vitro” response of gingival keratinocytes in terms of IL-6 production, cell growth and adhesion.
These findings may encourage a possible use of this collagen membrane as a tissue which, alone,
may substitute for autologous gingival grafts thereby overcoming the limitations of autologous
tissue.
Keratinized gingiva (KG) is a part of oral
mucosa covered with keratin or parakeratin
that includes the free and attached gingiva
(Gartner 1994). KG extends from the gingival
margin to the muco-gingival junction. Kerati-
nocytes account for 90% of the cell popula-
tion of KG. The more undifferentiated,
highly proliferating elements reside in the
basal stratum, linked to each other and
attached to the basal lamina by multiple
adhesion receptors including members of the
integrin family. Of particular interest are
a6b4 and a3b1 integrins, almost invariably
expressed on the surface of keratinocytes and
strategically localized at the lateral cell-cell
boundaries (a3b1) or at the cell-lamina inter-
face (a6b4). These integrins are able to recog-
nize multiple components of the extra-
cellular matrix (collagen, fibronectin, lami-
nin) and therefore to activate intracellular
signalling pathways, which regulate migra-
tion, proliferation, survival and differentia-
tion (Giancotti & Ruoslahti 1989; Sastry &
Horwitz 1996; Giancotti 1997; Mainiero
et al. 1998; Smith & Fuchs 1998). Keratino-
cyte differentiation progresses from the basal
to the stratified superficial layer, with cells
progressively acquiring size and expression of
higher molecular weight cytokeratins, mean-
while decreasing proliferation. This process
is governed by both intra- and extracellular
stimuli. Among them, detachment of a6b4
integrin from its natural ligand, for example
laminin 5, is one of the most effective (Sy-
minton & Carter 1995; Tennenbaum et al.
1996). In addition, epithelium growth factor
(EGF) stimulates basal keratinocyte mitosis
(Shirasuna et al. 1991; Whitcomb et al. 1993)
and interleukin 6 (IL-6) stimulates keratino-
cyte proliferation (Brauchle et al. 1994). The
end of the differentiation program is the for-
mation of keratinized (KG) or parakeratinized
gingiva, characterized by the expression of
cytokeratin 14, which can be considered a
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biochemical marker of the stratified squa-
mous epithelium (Moll et al. 1982; Cou-
lombe et al. 1989).
Some studies suggested that a minimum
width of KG is necessary to maintain gingi-
val health (Lang & Lo¨e 1972), whereas several
other have shown that the absence of KG is
compatible with the maintenance of peri-
odontal health (Dorfman et al. 1980; Wen-
nstro¨m et al. 1981; Wennstro¨m 1983;
Wennstro¨m & Lindhe 1983; Kennedy et al.
1985). However, clinical studies have shown
that lack of gingiva may occur in cases when
the absence of KG is combined with ortho-
dontic treatment or when vestibular depth is
needed in patients with removable partial
dentures or with subgingival crown margins
in patients with fixed prosthetic restorations
(Karring et al. 1971; Rateitschak et al. 1979;
De Trey & Bernimoulin 1980; Hangorsky &
Bissada 1980).
When dental implants are considered, it
has not been demonstrated that the presence
of keratinized mucosa (KM), the implant
counterpart of KG, is a prognostic factor for
their survival (Adell et al. 1986). However,
experimental studies in monkeys and
humans have demonstrated that the lack of
KM increases plaque accumulation around
implants, (Warrer et al. 1995; Chung et al.
2006) but the influence of this condition on
the survival of the dental implants has not
been demonstrated in humans (Chung et al.
2006). Furthermore, Zigdon & Machtei
(2008), have shown that both the peri-
implant width and thickness of KM may be
inversely correlated with recession of the
mucosa.
To augment gingival tissue dimensions,
the free gingival graft (Sullivan & Atkins
1969) and free connective tissue grafts have
been proposed (Edel 1998) with similar clini-
cal predictability (Roccuzzo et al. 2002). Cel-
lular dermal allografts have also been used to
overcome the limitation of source of donor’s
tissue, to reduce morbidity and to allow a
better colour and texture integration, but the
increase of KM may be less than with autoge-
nous transplant (Wei et al. 2000; Gapski
et al. 2005; Park 2006; Moharamzadeh et al.
2007; Thoma et al. 2009). Besides, in vitro
analysis suggests that fibroblast seeding on to
a cellular dermal allograft can allow for
favourable conditions for cell adhesion and
proliferation (Rodrigues et al. 2010).
The use of a tissue created by seeding oral
keratinocytes on collagen membranes of por-
cine origin, has also been evaluated (Xiong
et al. 2008). The fabricated palatal mucosa
equivalent may exhibit the characteristics of
the native counterpart, but this procedure
may be time consuming and expensive.
More recently the use of a collagen matrix
of porcine origin has proven to be as effective
and predictable as the connective tissue graft
for increasing the width of KG and to be
associated with a significantly lower patient
morbidity (Sanz et al. 2009; Herford et al.
2010; McGuire & Scheyer 2010; Jung et al.
2011).
The objective of this study is to test “in vi-
tro” a new collagen matrix of porcine origin
(CM-10826) produced by Geistlich Pharma
AG (Wolhusen, Switzerland) on seeded cells
from three human gingival biopsies of kerati-
nized mucosa. Initially, we investigated if
cells growing on the membrane were of epi-
thelial origin and would retain the features of
normal keratinized gingiva by evaluating the
expression of human MCH class I antigens
(MHC-I), EGF receptors (EGFR) and the pres-
ence of cytokeratin 14 (Moll et al. 1982; Cou-
lombe et al. 1989) and integrins a6b4 and
a3b1 (Giancotti & Ruoslahti 1989; Sastry &
Horwitz 1996; Giancotti 1997; Mainiero
et al. 1998; Smith & Fuchs 1998). Thereafter,
we investigated the effect of CM-10826 on
fundamental cell processes as adhesion, IL-6
production and proliferation of keratinocytes.
The ultimate aim of the membrane is to be a
material suitable for being grafted alone,
without any previous treatment, on a recipi-
ent site, instead of autologous gingival tissue.
Materials and methods
The experiments were undertaken with the
understanding and written consent of each
subject and according to ethical principles,
including the world medical association Dec-
laration of Helsinki (2008) and was indepen-
dently reviewed and approved by the ethical
board of the University of Verona (protocol
number 6640, project number 1085).
CM-10826 membrane, chemicals and antibodies
Collagen matrix 10826 made up of Collagen I
and III obtained from healthy pigs was kindly
provided by Geistlich Pharma AG. Sterility
was ensured by gamma irradiation. Media
were purchased from Seromed (Berlin, Ger-
many), supplements from Sigma (Milan,
Italy) and EGF from Austral Biological (San
Ramon, CA, USA). Foetal bovine serum (FBS)
was from Celbio (Pero, Milan, Italy); (Fab)2
goat anti-mouse immunoglobulins (Ig), anti-
integrin a3, a6 and b1 (CD29) were all from
Immunotech (Marseille, France). FITC-
labelled (Fab)2 goat anti-mouse Ig were from
Becton-Dickinson (San Jose`, CA, USA) and
mAb B9-12 (anti MCH Class I) were gifted by
Dr. R.S. Accolla, University of Pavia at
Varese, Italy. mAb 3E1 (anti- b4) was from
Calbiochem (La Jolla, CA, USA). Collagen I,
collagen IV, fibronectin and laminin, all from
pig origin, anti-EGFR and anti-cytokeratin 14
(CK14) were from Sigma.
“In vitro” derivation of human gingival
keratinocytes long-term cultures
Three independent gingival biopsies were
obtained from three independent healthy
patients under informed consent. Biopsies
were 5–10 mm wide specimens taken from
areas of KG and were executed in the Depart-
ment of Oral and Maxillofacial Surgery of the
University of Verona under local anaesthesia.
Primary cultures of gingival keratinocytes
were obtained as previously described (Green
et al. 1979) with minor modifications.
Briefly, tissue specimens were minced and
trypsinized (0.05% trypsin/0.01% EDTA) at
37°C for 3 h. Cells were collected every
30 min, pooled, plated onto lethally irradi-
ated 3T3-J2 cells (gift of Prof. H. Green, Har-
vard Medical School, Boston, MA) at
2.5 9 104/cm2 and cultured in humidified
atmosphere of 5% CO2 in DMEN (Dul-
becco’s Modified Eagle’s Medium) e Ham’s
F12 medium (2:1) with 10% FCS (Foetal Calf
Serum), insulin (5 lg/ml), transferrin (5 lg/
ml), adenine (0.18 nM), hydrocortisone
(0.4 lg/ml), choleric toxin (0.1 nM), triiodot-
ironin (2 nM), EGF (epithelial growth factor)
(10 ng/ml), glutamine (4 mM) and penicillin-
streptomycin (50 IU/ml). Primary cultures
were expanded into secondary cultures by
plating on feeder-layer cells before performing
experiments.
Immunofluorescence and immunohistochemistry
Immunofluorescence analysis was performed
according to standard techniques by using
FACScantocytofluorimeter (BD Bioscience,
San Jose, CA, USA). Samples stained with
mouse monoclonal antibodies anti-integrins
were mounted onto a glass cover coverlid and
examined using an Axioscope microscope
equipped for epifluorescence (Zeiss, Oberko-
chen, Germany). Images were recorded using
the Noah imaging software (Euroimmun,
Munich, Germany) and files assembled with
Adobe Photoshop 5.5 (Adobe System Inc.,
Mountain View, CA, USA).
Cell treatments
To perform adhesion tests keratinocytes were
detached by trypsin-EDTA treatment and
maintained in suspension (0.5 9 106 in
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1.5 ml of complete medium) for 6 h in the
incubator with or without fragments of CM-
10826 (3–5 mm2). Conical tubes were used to
avoid keratinocyte adhesion to the plastic.
Samples were stopped at 1, 3 and 6 h to num-
ber adherent cells and to evaluate cell viabil-
ity by Trypan Blue exclusion. For IL-6
production assays keratinocytes were plated
at 0.5 9 106 cell/well on 24 wells microtiter
plates previously coated with collagen I or
collagen IV, or fibronectin or laminin or CM-
10826. CM-10826 was carefully cut to fit the
well. Casein represented the experimental
control. Coating was carried by incubating
the plates for 18 h at 4°C with 10 lg/ml of
either protein in PBS. Unbound proteins were
extensively washed out with PBS. After 24 h
of culture the various supernatants were col-
lected, cell-cleared by centrifugation at 258 g
for 20 min and stored at 20°C. Adherent
keratinocytes were lysed for 30 min on ice
with a buffer composed of Tris 50 mM pH
7.5, NaCl 150 mM, Na pyrophosphate
2.5 mM, EDTA at 1% NP40 and protease
inhibitors at 1 mM concentration. Lysates
were cleared by micro centrifugation at 4°C
for 10 min, supernatants were aliquoted and
stored at 80°C. Total proteins recovered
from each well were quantified by Coomassie
protein assay reagent (Pierce, Rockford, IL,
USA). IL-6 concentration in cell-free superna-
tants was measured with an ELISA kit used
according to the manufacturer’s instructions
(Endogen, Woburn, MA, USA). Optical den-
sity (OD) values were plotted onto a standard
curve and expressed as pg/ml. Having mea-
sured the volume of cell-free supernatants of
each sample, IL-6 could be re-express as total
IL-6 for each and then calculated as pg IL-6
or CCL5/mg of protein lysate. Proliferation
assays were performed by plating keratino-
cytes (2 9 104 cell/well) in flat bottom 96-
well microtiter plates in complete medium
in the presence or absence of the various
ECM proteins coated as for IL-6 experiments.
Cultures were pulsed for 6H with 1lCi
[methyl-3H] thymidine (3H-TdR) (6.7 Ci/
mmol) from NEN Dupont (Boston, MA,
USA). Cells were harvested onto glass-fibre
filters and radioactivity measured in a beta-
spectrometer. Results were expressed as the
percentage of incorporation of the untreated
control.
Statistical analysis
Results were obtained in three independent
experiments performed in duplicate, or, in
the case of thymidine incorporation, in tripli-
cate, and analysed by paired t-test after
checking for the normality assumption. A
total of 18 stimulated cultures (i.e. with CM-
10826) and 18 untreated control (i.e. without
CM-10826) were paired for all the biological
assays. Significance was considered when
P < 0.05.
Results
Physical and chemical features of CM-10826
CM-10826 is classified as a implantable,
resorbable medical device class II, allowed to
permanent contact with the bone and the
periosteum. Cellular components and other
molecules are removed with a standardized
purification process, whereas collagen is kept
in a native form. Collagen fibres are made up
of 50–80 nm fibrils. As shown in Fig. 1 the
membrane is build up as 3D-matrix with two
juxtaposed layers: soft stratum is structured
with open pore sponge system in which pores
are organized in a 3-D network with a diame-
ter ranging from 40 to 60 lm; hard stratum is
composed of compact collagen fibres which
allow suturing procedures. The micropores
width is intended to facilitate fibroblast
migration, angiogenesis and to stimulate
resident keratinocytes’ growth (Rutkowski
2006).
Biological features of human gingival
keratinocytes cultures
As shown in Fig. 2a cultured keratinocytes
maintained “in vitro” the ability to form
cohesive monolayers. As shown in Fig. 2b,
results of FACS analysis showed that virtu-
ally all these cells co-expressed high amounts
of human MHC-I, EGFR and cytokeratine
CK-14 (CK14) together with a3 integrin, part-
ner of b1 chain in the formation of the fibro-
nectin adhesion receptor a3b1, and a6
integrin, partner of b4 chain in the formation
of the laminin receptor a6b4. Moreover, as
shown in Fig. 2c cell distribution of the fibro-
nectin and the laminin receptors (a3b1 and
a6b4 integrin heterodimers) was similar to
that displayed by normal epithelia “in vivo”
(De Luca et al. 1990).
Gingival keratinocytes adhere to CM-10826
Biological outcomes of the CM-10826/kerati-
nocyte interaction were examined. As shown
in Fig. 3a keratinocytes adhered to CM-10826
in a time-dependent manner, from the 25%
observed at 1 h to the 60% at 3 h and almost
the 70% (67 ± 5%, P < 0.05) of the starting
population attached to Collagen Matrix
10826 6 h later following the first contact.
The CM-10826/keratinocytes adhesion was
further examined by thin layer microscopy
(Fig. 3b,c). Keratinocytes adhered firmly to
CM-10826, grow on the surface, spread their
large cytoplasm and interconnect with neigh-
bouring elements.
Gingival keratinocytes increase their IL-6
production in the presence of CM-10826 and
proliferate in the presence of collagen I, a
major component of this device
It is known that cell adhesion activates intra-
cellular signalling pathways governing a mul-
tiplicity of cellular processes including the
gene expression of cytokines, such as IL-6
(Ramarli et al. 1998). As evident from Fig. 4a
the basal IL-6 production was doubled in the
presence of CM-10826, strongly increased in
the presence of a major component of CM-
10826, whereas collagen IV appeared almost
unaffected. Collagen I was also found to act
as the best stimulator of proliferation of
keratinocytes, measured by thymidine uptake
(Fig. 4b). CM-10826 could not be directly
tested in proliferation assays because it was
impossible to melt it in the reagent required
to measure the H3-thymidine incorporation
without quenching the results. However, the
pro-proliferative activity of Collagen I
strongly suggests that the CM-10826 may act
in the same way.
Discussion
The aim of our study was to evaluate the
activity of a newly engineered collagen mem-
brane Collagen Matrix 10826 (CM-10826) on
fundamental cell functions of human gingival
keratinocytes, such as adhesion, IL-6 produc-
tion and proliferation, and therefore to estab-
lish the degree of specific biocompatibility of
this new device.
Initially cytofluorimetric and immunohis-
tochemical analysis on keratinocyte cultures
were done. They showed the epithelial kera-
tinized phenotype of the cells by the presence
of CK14 and EGFR, as confirmed in literature
Fig. 1. Electron-micro photography of new collagen
matrix 10826 showing the hard layer and soft layer
(Kindly supplied by Geistlich Pharma AG Wolhusen,
Switzerland).
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(Moll et al. 1982; Coulombe et al. 1989; De
Luca et al. 1990). Secondarily the keratino-
cytes’ capacity of making cohesive monolay-
ers by the expression of fibronectin and
laminin receptors, cytokines, chemokines
and cell growth factors (De Luca et al. 1990)
was also demonstrated. Cell distribution of
the fibronectin and the laminin receptors
(a3b1 and a6b4 integrin heterodimers) was
similar to that displayed by normal epithelia
“in vivo” (De Luca et al. 1990). Results
obtained by thin layer microscopy demon-
strated that keratinocytes adhered firmly to
CM-10826, grew on the surface, spread their
large cytoplasm and interconnects with
neighbouring elements.
These results suggested that gingival kerat-
inocytes derived in culture displayed the typ-
ical features of normal keratinized
epithelium.
In addition, keratinocytes were used as
cohesive and homogeneous monolayers to
obtain a representation of “in vivo” physio-
logical situation which let us perform func-
tional tests as the adhesion, IL-6 cytokine
production and keratinocyte proliferation.
Adhesion was efficient as it occurred rap-
idly and the mortality was low. Collagen
matrix 10826 and collagen I adherent cells
were stimulated to produce a significant
increase of IL-6 their production. Thus, sig-
nificantly high production of IL-6, an anti-
apoptosis molecule, could increase the cell-
protection from their spontaneous apoptosis
(212 ± 32%, P < 0.01 compared with
untreated controls). Moreover, a similar effect
was observed in the presence of Collagen I, a
major component of Collagen Matrix 10826.
The cell-proliferation test, by tritiated
thymidine cell-incorporation measurement
(3H-Thymidine), showed a significant




Fig. 2. Representative morphology and phenotype of keratinocytes at the second passage of culture. All results are representative of three independent experiments. (a) Cohesive
monolayer of gingival keratinocytes examined at the inverted microscope (209 magnification). (b) Phenotype assessed by FACS analysis considering MHC-class I molecules
(MHC-I), a3 (3) or a6 (6) integrands, EGF receptors (EGFR) and cytokeratin (CK14). (c) s1 (1) or s4 (4) expression at the surface of keratinocytes examined at 409 magnification.
Arrows indicate peculiar site of localization.
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cytes on collagen I and IV. The significant
tritiate-thymidine incorporation in keratino-
cytes during adhesion to collagen I and colla-
gen IV (basal components of collagen matrix
10826) suggested that keratinocyte prolifera-
tion on this new membrane is similar
(380 ± 52%, P < 0.001 compared with
untreated controls). Proliferation experiments
demonstrated that the best response was
observed in the presence of Collagen I, the
main component of CM-10826. No undesired
effects were observed as for keratinocytes via-
bility, morphology or differentiation.
In summary, CM-10826 demonstrated a
positive biological activity on gingival kerati-
nocytes supporting IL-6 production and cell
growth and adhesion, without any toxic
effect. It appears that CM-10826 alone might
function in oral surgery as a substitute for
autologous gingival grafts thereby overcom-
ing the limitations of autologous tissue.
Besides, the maintenance of the keratinized
phenotype of cell-culture may encourage a
possible use of this collagen membrane to
obtain augmentation of keratinized gingiva.
We have tested the effect of CM-10826 on
gingival cells “in vitro” but the outcomes of
this analysis will be part of a wider preclini-
cal study, which is going to test the clinical
efficacy of the membrane alone on animals
and on patients.
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